CMS Drug Price Negotiation Guidance Updates with Rachel Sachs

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/b4/84/cb/b484cbc8-4463-cf6e-804e-e73f4ec79306/mza_17835609594961865008.jpg/600x600bb.jpg

Health Affairs This Week

Health Affairs

243 episodes

1 day ago

Health Affairs This Week places listeners at the center of health policy’s proverbial water cooler. Join editors from Health Affairs, the leading journal of health policy research, and special guests as they discuss this week’s most pressing health policy news. All in 15 minutes or less.

Health & Fitness

News

RSS

All content for Health Affairs This Week is the property of Health Affairs and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Health & Fitness

News

CMS Drug Price Negotiation Guidance Updates with Rachel Sachs

Health Affairs This Week

17 minutes

1 week ago

CMS Drug Price Negotiation Guidance Updates with Rachel Sachs

Subscribe to UnitedHealthcare's Community & State newsletter.

Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back to the pod to discuss CMS' final guidance for the latest round of the Medicare drug price negotiation program.

Related Articles:

Administration Releases Medicare Drug Price Negotiation Program Final Guidance For 2028 (Health Affairs Forefront)
The Role of Combination Drugs in the Medicare Drug Price Negotiation Program (JAMA)
Articulating policy options regarding implementation of the Medicare drug price negotiation program’s renegotiation provision (Brookings Institution)
Eye on The IRA (Health Affairs)

Subscribe to UnitedHealthcare's Community & State newsletter.